C.M. Bidwell & Associates »

Protalix Biotherapeutics shares owned by C.M. Bidwell & Associates

Quarter-by-quarter ownership of Protalix Biotherapeutics (PLX) shares owned by C.M. Bidwell & Associates from 13F filings

Historical chart of C.M. Bidwell & Associates investment in Protalix Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protalix Biotherapeutics held by C.M. Bidwell & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protalix Biotherapeutics by C.M. Bidwell & Associates

Quarter filed Position value Share count Share price at filing
2026-03-31 $512 236 2.17

More positions owned by C.M. Bidwell & Associates

Vanguard S&p 500 Etf idx (VOO)
Vanguard Short-Term Bond ETF (BSV)
Schwab Strategic Tr sht tm us tres (SCHO)
Vanguard Malvern Fds strm infproidx (VTIP)
Vanguard Total Stock Market ETF (VTI)
iShares Russell 2000 Index (IWM)
iShares Brclys Intrdte Gov/Crt Bd (GVI)
iShares S&P 500 Index (IVV)
Vanguard Europe Pacific ETF (VEA)
Ishares Tr core strm usbd (ISTB)
iShares MSCI ACWI ex US Index Fund (ACWX)
Vanguard Total Bond Market ETF (BND)
Schwab Strategic Tr 0 (SCHP)
Dimensional Etf Trust (DFAC)
Vanguard Intermediate-Term Bond ETF (BIV)

View all positions for C.M. Bidwell & Associates

Top funds holding Protalix Biotherapeutics

BlackRock
MAK Capital One
Renaissance Technologies
State Street Corporation
Northern Trust
Geode Capital Management
Stratos Wealth Partners
Vanguard Portfolio Management
Prospera Financial Services
Opaleye Management
Morgan Stanley
Dimensional Fund Advisors
Susquehanna International
UBS Group
Goldman Sachs Group

View all funds holding Protalix Biotherapeutics